We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Zero-Footprint Interoperable Image-Viewing Software Uses Data More Effectively

By MedImaging International staff writers
Posted on 29 Feb 2012
Print article
New image viewing software provides interoperable image exchange and management, and is an enabling technology that reduces or eliminates many hurdles to efficiency in healthcare organizations.

Merge Healthcare (Chicago, IL, USA), a provider of enterprise imaging and interoperability solutions, announced that Merge iConnect was presented at the HIMSS12 Interoperability Showcase at the 2012’s HIMSS (Healthcare Information and Management Systems Society) conference in Las Vegas, February 21-24, 2012.

“We’re proud that iConnect is part of the Interoperability Showcase at HIMSS, and of the collaborative effort that is taking place among healthcare IT [information technology] vendors to ensure interoperability among the myriad of systems and interfaces hospitals use to share data,” said Jeff Surges, CEO, Merge Healthcare. “Attendees will see first-hand how interoperable systems, like iConnect Access, communicate with one another better, are easier to implement, and enable providers to use information more effectively.”

Merge iConnect Access provides a true zero-footprint image viewing capability and can be embedded into many third-party products. iConnect Access is part of the iConnect product range, which is the only comprehensive solution for collecting, archiving, viewing, sharing, and exchanging any type of image, anywhere, any time.

Merge’s client base covers 1,500 hospitals and 6,000 clinics. iConnect is in use at some of the largest and most prestigious hospitals and healthcare systems. Merge iConnect Access successfully completed testing for all registered Integration Profiles at the Integrating the Healthcare Enterprise Connectathon held January 2012 in Chicago, IL, USA. Merge Healthcare successfully assessed with 25 different vendors and its solutions met all required functionality and interoperability requirements including the IHE ATNA (Integrating the Healthcare- Enterprise Audit Trail and Node Authentication) security profile.

Merge completed six IHE Integration Profiles, including consistent time (CT), ATNA, cross-enterprise document sharing-b (XDS.b), cross-enterprise document sharing for imaging (XDS-I.b), patient identifier cross-referencing (PIX), and patient demographics query (PDQ). This confirms that Merge iConnect Access can be used in IHE XDS (cross enterprise document sharing) solutions including Health Information Exchanges (HIE) and Accountable Care Organizations (ACO) around the world.

The IHE Connectathon is the healthcare IT industry’s only large-scale interoperability testing event. It provides detailed validation of the participants’ interoperability and compliance with IHE profiles. During the Connectathon systems exchange information with complementary systems from multiple vendors, performing all of the transactions required for the roles they have selected, called IHE Actors, in support of defined clinical use cases, called IHE Profiles. Thousands of vendor-to-vendor connections have been tested overall, and tens of thousands of transactions passed among the systems tested.

Related Links:

Merge Healthcare


Silver Member
X-Ray QA Meter
T3 AD Pro
Ultrasound Imaging System
P12 Elite
New
Biopsy Software
Affirm® Contrast
X-ray Diagnostic System
FDX Visionary-A

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.